Cite
HARVARD Citation
Allanore, Y. et al. (n.d.). OP0250 EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY. Annals of the rheumatic diseases. pp. 157-158. [Online].